Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDER  ·  FREE SHIPPING OVER $300 CAD  ·  COA ON REQUEST
Cognitive Research6 min read

Selank: A Research Overview of the Anxiolytic Peptide

Developed in Moscow in the 1990s, Selank has remained largely unknown outside of specialized research circles. That's starting to change — and Canadian researchers are paying close attention.

selankselank nasal sprayanxiety researchnootropiccognitive peptides canadagababdnfselank 10ml nasal spraybuy selank 10ml nasal spray canadalimitless stack
By Popular PeptidesPublished Updated
  • Selank is a synthetic heptapeptide analogue of tuftsin developed in Moscow in the 1990s, studied for anxiolytic effects without the sedation of classical GABA-enhancing compounds.
  • It appears to modulate GABAergic tone differently, with additional studied interactions across serotonin, dopaminergic pathways, and BDNF expression.
  • Preclinical studies show Selank upregulates BDNF in several brain regions — a research angle distinct from its anxiolytic properties.
  • The intranasal route provides direct olfactory-pathway CNS access, aligning with the delivery method most common in the published literature.
  • Popular Peptides supplies Selank Nasal Spray (10 ml) at ≥99% purity, independently third-party tested with a COA; research use only.

The Peptide Developed Behind the Iron Curtain

In the 1990s, researchers at the Institute of Molecular Genetics in Moscow developed a synthetic heptapeptide with an unusual property: it appeared to reduce anxiety in preclinical models without producing sedation.

They called it Selank.

For decades, Selank remained largely confined to Russian and Eastern European research literature — studied extensively but not widely known in Western research circles. That is beginning to change, and Canadian researchers studying cognitive health, stress physiology, and anxiety biology are increasingly interested in what the literature says.

What Makes Selank Unique

Most compounds studied for anxiolytic effects share a common mechanism: they enhance GABA activity, the brain's primary inhibitory neurotransmitter. The problem is that enhancing GABA often produces sedation, cognitive impairment, and dependency — major limitations for research applications and therapeutic development.

Selank appears to modulate GABA differently. Preclinical research suggests it enhances GABAergic tone without the sedation profile of classical GABA-enhancing compounds. Researchers have also identified interactions with serotonin metabolism, dopaminergic pathways, and BDNF (Brain-Derived Neurotrophic Factor) expression.

This selectivity profile makes Selank a valuable research tool for investigators who want to study anxiolytic mechanisms without the confounding variables introduced by classical benzodiazepine-like compounds.

The BDNF Connection

BDNF is a neurotrophin that supports the growth, maintenance, and differentiation of neurons. It has been extensively studied in the context of depression, anxiety, cognitive function, and neuroplasticity. Research has suggested that reduced BDNF expression is associated with stress-related disorders in animal models.

Selank has been shown in preclinical studies to upregulate BDNF expression in several brain regions. This effect is separate from its anxiolytic properties and represents a distinct research angle — particularly for investigators exploring the relationship between stress, BDNF, and cognitive performance.

Nasal Spray Delivery for CNS Research

The intranasal delivery route offers particular advantages for compounds that interact with central nervous system receptors. The olfactory pathway provides direct anatomical access to brain tissue, bypassing the blood-brain barrier and hepatic metabolism.

For Selank research specifically — where CNS receptor interactions are the primary area of interest — the nasal spray format aligns with the delivery route most commonly used in the published literature.

Popular Peptides supplies Selank Nasal Spray (10ml) as a research-grade compound for Canadian investigators. ≥99% purity, independently third-party tested, Certificate of Analysis included.

**Disclaimer**: For laboratory and research use only. Not approved by Health Canada for therapeutic use.

What to order

Compounds referenced in this guide:

Popular Peptides ships from Vancouver, BC — typically 2 to 5 business days, tracked and insured, with no customs clearance and no border seizure risk. Every batch is third-party tested (HPLC for purity, LC-MS for identity) and its certificate of analysis is retrievable by lot number. Priced in Canadian dollars, free shipping over $300 CAD.

Browse every published lab result before you order, or check the reference library for molecular data on each compound.

Frequently asked questions

What is Selank?

A synthetic heptapeptide studied in anxiolytic and nootropic research contexts.

How does Selank relate to Semax?

Both are synthetic peptides studied in neuroscience research and both are available as pre-mixed nasal sprays, but they are structurally distinct — Semax derives from an ACTH fragment.

Is a lyophilised version available?

Yes — Selank is listed as a lyophilised powder as well as a nasal spray.

Every batch we sell is independently third-party tested, with the full Certificate of Analysis published and checkable by lot number.